Metrics to evaluate the performance of auto-segmentation for radiation treatment planning: A critical review.

Journal: Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology
PMID:

Abstract

Advances in artificial intelligence-based methods have led to the development and publication of numerous systems for auto-segmentation in radiotherapy. These systems have the potential to decrease contour variability, which has been associated with poor clinical outcomes and increased efficiency in the treatment planning workflow. However, there are no uniform standards for evaluating auto-segmentation platforms to assess their efficacy at meeting these goals. Here, we review the most frequently used evaluation techniques which include geometric overlap, dosimetric parameters, time spent contouring, and clinical rating scales. These data suggest that many of the most commonly used geometric indices, such as the Dice Similarity Coefficient, are not well correlated with clinically meaningful endpoints. As such, a multi-domain evaluation, including composite geometric and/or dosimetric metrics with physician-reported assessment, is necessary to gauge the clinical readiness of auto-segmentation for radiation treatment planning.

Authors

  • Michael V Sherer
    Department of Radiation Medicine and Applied Sciences, University of California San Diego, La Jolla, United States.
  • Diana Lin
    Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, United States.
  • Sharif Elguindi
    Department of Medical Physics, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.
  • Simon Duke
    Department of Oncology, Cambridge University Hospitals, United Kingdom.
  • Li-Tee Tan
    Department of Oncology, Cambridge University Hospitals, United Kingdom.
  • Jon Cacicedo
    Department of Radiation Oncology, Cruces University Hospital/BioCruces Health Research Institute, Osakidetza, Barakaldo, Spain.
  • Max Dahele
    Department of Radiotherapy, VU University Medical Center, Amsterdam, The Netherlands.
  • Erin F Gillespie
    Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, United States. Electronic address: efgillespie@ucsd.edu.